Concepedia

Xiaoling Luo

XL

Statistics

Publications

4

Citations

244

H-Index

4

Active since

2012

Affiliations

Leidos (United States)(Current)

National Center for Advancing Translational Sciences

National Institutes of Health

Xinjiang Academy of Agricultural and Reclamation Science

Xiaoling Luo is an author at Leidos (United States) specializing in molecular oncology, mek signaling, and mek inhibition.

Publications per year

2012–2022

4

Publications

4

MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma

Marielle E. Yohe, Berkley E. Gryder, Jack F. Shern et al. · Science Translational Medicine · 2018 · 153 citations · Full text

Medicine, Molecular Biology, Oncology +17

Synthesis of hyperbranched polymers and their applications in analytical chemistry

Fengxia Sun, Xiaoling Luo, Lichao Kang et al. · Polymer Chemistry · 2014 · 51 citations

Natural Sciences, Chemistry, Materials Science +16

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Katie E. Hebron, Xiaolin Wan, Jacob S. Roth et al. · Clinical Cancer Research · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessment of antibacterial properties and the active ingredient of plant extracts and its effect on the performance of crucian carp (<i>Carassius auratus gibelio</i> var. <i>E'erqisi</i>, Bloch)

Chunxia Lu, Xiaoling Luo, Ruifeng Luo et al. · Journal of the Science of Food and Agriculture · 2012 · 19 citations · Full text

Agriculture, Botany, Plant Sciences +16

1–4 of 4